Amplia Therapeutics Ltd. (AU:ATX) has released an update.
Amplia Therapeutics Limited has announced the cessation of 500,000 options due to their expiry without exercise or conversion as of May 10, 2024. The financial community is advised of this change in the company’s issued capital, a detail that might interest shareholders and potential investors. This update marks a new announcement in the company’s financial calendar and could have implications for its stock valuation.
For further insights into AU:ATX stock, check out TipRanks’ Stock Analysis page.
